97 related articles for article (PubMed ID: 15180863)
1. Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma.
Brown R; Murray A; Pope B; Sze DM; Gibson J; Ho PJ; Hart D; Joshua D
Br J Haematol; 2004 Jun; 125(6):743-8. PubMed ID: 15180863
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
[TBL] [Abstract][Full Text] [Related]
3. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
4. Impaired circulating myeloid DCs from myeloma patients.
Do TH; Johnsen HE; Kjaersgaard E; Taaning E; Svane IM
Cytotherapy; 2004; 6(3):196-203. PubMed ID: 15203976
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.
Brown RD; Pope B; Murray A; Esdale W; Sze DM; Gibson J; Ho PJ; Hart D; Joshua D
Blood; 2001 Nov; 98(10):2992-8. PubMed ID: 11698282
[TBL] [Abstract][Full Text] [Related]
6. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response.
Flohé SB; Agrawal H; Schmitz D; Gertz M; Flohé S; Schade FU
J Leukoc Biol; 2006 Mar; 79(3):473-81. PubMed ID: 16365154
[TBL] [Abstract][Full Text] [Related]
8. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
Feili-Hariri M; Falkner DH; Morel PA
J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
[TBL] [Abstract][Full Text] [Related]
9. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
10. Development of an effective method for dendritic cell immunotherapy of mouse melanoma.
Lee TH; Cho HK; Cho YH; Lee MG
Scand J Immunol; 2009 Aug; 70(2):85-92. PubMed ID: 19630913
[TBL] [Abstract][Full Text] [Related]
11. Cytokine maturation followed by CD40L mRNA electroporation results in a clinically relevant dendritic cell product capable of inducing a potent proinflammatory CTL response.
Calderhead DM; DeBenedette MA; Ketteringham H; Gamble AH; Horvatinovich JM; Tcherepanova IY; Nicolette CA; Healey DG
J Immunother; 2008 Oct; 31(8):731-41. PubMed ID: 18779746
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer of CD40-ligand to dendritic cells stimulates interferon-gamma production to induce growth arrest and apoptosis of tumor cells.
Tomihara K; Kato K; Masuta Y; Nakamura K; Uchida H; Sasaki K; Tanaka T; Huang J; Hiratsuka H; Hamada H
Gene Ther; 2008 Feb; 15(3):203-13. PubMed ID: 17989706
[TBL] [Abstract][Full Text] [Related]
13. Regulation of immune responses to Mycobacterium tuberculosis secretory antigens by dendritic cells.
Latchumanan VK; Balkhi MY; Sinha A; Singh B; Sharma P; Natarajan K
Tuberculosis (Edinb); 2005; 85(5-6):377-83. PubMed ID: 16246624
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
15. CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1.
Pilon C; Levast B; Meurens F; Le Vern Y; Kerboeuf D; Salmon H; Velge-Roussel F; Lebranchu Y; Baron C
Mol Immunol; 2009 Jan; 46(3):437-47. PubMed ID: 19036453
[TBL] [Abstract][Full Text] [Related]
16. CD40L stimulation of rat dendritic cells specifically favors the IL-12/IL-10 ratio resulting in a strong T cell stimulatory capacity.
Stax AM; Crul C; Kamerling SW; Schlagwein N; van der Geest RN; Woltman AM; van Kooten C
Mol Immunol; 2008 May; 45(9):2641-50. PubMed ID: 18262271
[TBL] [Abstract][Full Text] [Related]
17. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
[TBL] [Abstract][Full Text] [Related]
18. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
Jun HX; Jun CY; Yu ZX
Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma.
Laouar Y; Sutterwala FS; Gorelik L; Flavell RA
Nat Immunol; 2005 Jun; 6(6):600-7. PubMed ID: 15852008
[TBL] [Abstract][Full Text] [Related]
20. Phenotype and function of myeloid dendritic cells derived from African green monkey blood monocytes.
Mortara L; Ploquin MJ; Faye A; Scott-Algara D; Vaslin B; Butor C; Hosmalin A; Barré-Sinoussi F; Diop OM; Müller-Trutwin MC
J Immunol Methods; 2006 Jan; 308(1-2):138-55. PubMed ID: 16325847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
